Novozymes A/S Alpha-Amylase Enzyme Variants and Polynucleotides Patent Application
Summary
Novozymes A/S has filed US Patent Application US20260109960A1 (Application No. 19363135) titled 'ENZYME VARIANTS AND POLYNUCLEOTIDES ENCODING THE SAME', published April 23, 2026, with a filing date of October 20, 2025. The application covers polypeptides with alpha-amylase activity, encoding polynucleotides, nucleic acid constructs, vectors, host cells, and associated production methods. CPC classifications include C12N 9/2414, C11D 3/386, and related biotechnological categories indicating commercial applications in cleaning products and industrial enzyme production. Eight named inventors are listed, including Torsten Bak Regueira, Bitten Plesner, Thomas Holberg Blicher, Anne Dorte Houg, Sofia Arnehed, Lars Lehmann Hylling Christensen, and Carsteen Andersen.
“The present invention relates to polypeptide having alpha-amylase activity.”
About this source
GovPing monitors USPTO Patent Applications - Biotech (C12N) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 236 changes logged to date.
What changed
Novozymes A/S filed US Patent Application US20260109960A1 on October 20, 2025, published April 23, 2026, seeking exclusive rights to enzyme variants with alpha-amylase activity, the polynucleotides encoding those variants, and associated nucleic acid constructs, vectors, host cells, and methods of use. The application is classified under multiple CPC codes including C12N 9/2414 (amylases), C11D 3/386 (enzyme preparations for cleaning), and C12N 15/52 (recombinant DNA technology, indicating biotechnological production methods.
Parties in the industrial enzyme sector, particularly firms developing or commercializing alpha-amylase products for cleaning, textile, or food-processing applications, should monitor this application through the USPTO's public dossier. Competitors may wish to conduct freedom-to-operate analyses as the claims mature toward grant, particularly in jurisdictions where Novozymes holds corresponding foreign filings.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
ENZYME VARIANTS AND POLYNUCLEOTIDES ENCODING THE SAME
Application US20260109960A1 Kind: A1 Apr 23, 2026
Assignee
Novozymes A/S
Inventors
Torsten Bak Regueira, Bitten Plesner, Thomas Holberg Blicher, Anne Dorte Houg, Sofia Arnehed, Lars Lehmann Hylling Christensen, Carsten Andersen
Abstract
The present invention relates to polypeptide having alpha-amylase activity. The present invention also relates to polynucleotides encoding the polypeptides; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the polypeptides.
CPC Classifications
C12N 9/2414 C11D 3/386 C12N 1/14 C12N 1/20 C12N 9/2417 C12N 15/52 C12N 15/63 C12Y 302/01001
Filing Date
2025-10-20
Application No.
19363135
Parties
Related changes
Get daily alerts for USPTO Patent Applications - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.